adalimumab
(adalimumab-fkjp)Biocon Biologics Inc
Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).